NEW YORK, May 24 - Proteomics startup ActivX Biosciences has appointed David Campbell, formerly director of discovery chemistry at Bayer, to the position of vice president of chemistry, the company said Thursday. 

At ActivX Campbell will be responsible for overseeing all chemistry programs at the company. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.